Endothelin-1 concentrations are correlated with the severity of knee osteoarthritis

Zhe Zhao1, Enqi Li2, Qing Cao2

  • 1Department of Surgery of Traditional Chinese Medicine, Tianjin Hospital, Tianjin, People's Republic of China.

Insights

Elevated endothelin-1 levels correlate with knee osteoarthritis (OA) development and severity. Higher concentrations in serum and synovial fluid are linked to increased joint damage, indicating its role in OA progression.

Area of Science:

  • Biomedical research
  • Orthopedics
  • Rheumatology

Background:

  • Endothelin-1 is a potent vasoconstrictor implicated in articular cartilage destruction.
  • Understanding its role in knee osteoarthritis (OA) is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the association between endothelin-1 concentrations and the development and severity of knee OA.
  • To determine if endothelin-1 levels correlate with radiographic OA grading.

Main Methods:

  • A cohort of 209 knee OA patients was studied.
  • Serum and synovial fluid (SF) endothelin-1 levels were measured.
  • Osteoarthritis severity was assessed using Kellgren-Lawrence (KL) grading.

Main Results:

  • Patients with knee OA exhibited higher serum endothelin-1 concentrations compared to controls.
  • Significantly elevated serum and SF endothelin-1 levels were observed in patients with higher KL grades.
  • A strong positive correlation was found between endothelin-1 concentrations (serum and SF) and KL grades.

Conclusions:

  • Serum and synovial fluid endothelin-1 concentrations are significantly correlated with knee OA development and progression.
  • Endothelin-1 may serve as a biomarker for OA severity and a potential therapeutic target.

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
544
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.8K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.8K